The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas
出版年份 2016 全文链接
标题
The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 115, Issue 4, Pages 454-464
出版商
Springer Nature
发表日期
2016-07-22
DOI
10.1038/bjc.2016.187
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Germ cell neoplasiain situ(GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy
- (2016) Daniel M Berney et al. HISTOPATHOLOGY
- The Transcriptome and DNA Methylome Landscapes of Human Primordial Germ Cells
- (2015) Fan Guo et al. CELL
- A Unique Gene Regulatory Network Resets the Human Germline Epigenome for Development
- (2015) Walfred W.C. Tang et al. CELL
- SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate
- (2015) Naoko Irie et al. CELL
- BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma
- (2015) Daniel Nettersheim et al. PLoS Genetics
- SOX17 links gut endoderm morphogenesis and germ layer segregation
- (2014) Manuel Viotti et al. NATURE CELL BIOLOGY
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
- (2013) Angelique W. Whitehurst Annual Review of Pharmacology and Toxicology
- Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm
- (2013) Irene Aksoy et al. EMBO JOURNAL
- Transcription Factor TFAP2C Regulates Major Programs Required for Murine Fetal Germ Cell Maintenance and Haploinsufficiency Predisposes to Teratomas in Male Mice
- (2013) Jana Schemmer et al. PLoS One
- Increased PRAME-Specific CTL Killing of Acute Myeloid Leukemia Cells by Either a Novel Histone Deacetylase Inhibitor Chidamide Alone or Combined Treatment with Decitabine
- (2013) Yushi Yao et al. PLoS One
- Analysis of TET Expression/Activity and 5mC Oxidation during Normal and Malignant Germ Cell Development
- (2013) Daniel Nettersheim et al. PLoS One
- Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cells
- (2012) Daniel Nettersheim et al. GENES CHROMOSOMES & CANCER
- NANOG promoter methylation and expression correlation during normal and malignant human germ cell development
- (2011) Daniel Nettersheim et al. Epigenetics
- The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression
- (2011) Daniel Nettersheim et al. GENES CHROMOSOMES & CANCER
- TGF-β1, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma
- (2011) D. Nettersheim et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Analysis of Gene Expression Profiles of Microdissected Cell Populations Indicates that Testicular Carcinoma In situ Is an Arrested Gonocyte
- (2009) S. B. Sonne et al. CANCER RESEARCH
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications
- (2008) J de Jong et al. JOURNAL OF PATHOLOGY
- Characteristics of testicular dysgenesis syndrome and decreased expression ofSRYandSOX9in Frasier syndrome
- (2008) Valérie Schumacher et al. MOLECULAR REPRODUCTION AND DEVELOPMENT
- Genome-wide analysis of cancer/testis gene expression
- (2008) O. Hofmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started